LG Life Sciences signs drug export deal

Published: 2010-01-14 06:56:00

Updated: 2010-01-14 06:56:00

LG Life Sciences, a local drug maker, said on January 12 that it has signed a contract with a China pharmaceutical company to export a newly developed substance for a drug to cure diabetes.

The deal with Beijing Double-Crane Pharmaceutical Co., Ltd. (DCPC) was in the scale of $4 million, acco...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK